Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III
Haeny AM, Oluwoye O, Cruz R, Iheanacho T, Jackson AB, Fisher S, Crouch M, O'Malley S. Drug and alcohol treatment utilization and barriers among Black, American Indian/Alaskan Native, Latine, Asian/Pacific Islander/Native Hawaiian, and White adults: Findings from NESARC-III. Journal Of Substance Use And Addiction Treatment 2021, 131: 108569. PMID: 34393011, PMCID: PMC9084614, DOI: 10.1016/j.jsat.2021.108569.Peer-Reviewed Original ResearchConceptsAI/AN adultsAlcohol treatment utilizationAI/ANsTreatment utilizationAlcohol use disorderWhite adultsBlack adultsDUD treatmentLifetime alcohol use disorderAmerican Indians/Alaska NativesAmerican Indian/Alaskan NativeHealth care professionalsNational Epidemiological SurveyEthnic groupsNative HawaiiansOutpatient programEpidemiological dataCare professionalsUse disordersAUD treatmentEpidemiological surveySecondary analysisSocial determinantsRelated conditionsNESARC-IIIThe effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials
Haeny AM, Gueorguieva R, Montgomery L, Bold KW, Fucito LM, Wu R, Muvvala SB, Zweben A, O'Malley SS. The effect of varenicline on smoking and drinking outcomes among Black and White adults with alcohol use disorder and co-occurring cigarette smoking: A secondary analysis of two clinical trials. Addictive Behaviors 2021, 122: 106970. PMID: 34216871, PMCID: PMC9426655, DOI: 10.1016/j.addbeh.2021.106970.Peer-Reviewed Original ResearchConceptsEffects of vareniclineAlcohol use disorderCigarette smokingClinical trialsUse disordersWhite adultsEfficacy of vareniclineNumber of drinksVareniclineSmokingPrimary analysisAlcohol treatmentSecondary analysisAlcohol useTrialsBlack participantsDrinking outcomesLinear mixed modelsAdultsWhite peopleWhite participantsMixed modelingCigarettesDisordersTreatment